News
Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?
NTMir Wins Best Media Relations Campaign Award for World NTM Awareness Day
We’re thrilled to announce that NTM Info & Research (NTMir) has been honored with the Best Media Relations Campaign award at the 2025 Association Insights CommImpact Awards for our World NTM Awareness Day initiative! Presented by OnWrd & UpWrd, the...
New Research Initiative Tackles Safety Concerns for NTM Lung Disease Patients
New Research Initiative Tackles Safety Concerns for NTM Lung Disease Patients A collaborative research project is underway to provide the first scientific evidence on sterilization methods used by patients with nontuberculous mycobacterial (NTM) lung disease and...
his Holiday Season, Give Hope. Give Connection. Give to NTMir.
🎁 This Holiday Season, Give Hope. Give Connection. Give to NTMir. As the year comes to a close, we’re reflecting on how far we’ve come — and how your generosity continues to make it all possible. In 2025, the impossible became reality: the first-ever FDA-approved...
🫁 Myth vs. Fact: Understanding NTM Lung Disease
🫁 Myth vs. Fact: Understanding NTM Lung Disease What Is NTM Lung Disease? Nontuberculous Mycobacterial (NTM) lung disease is a chronic infection caused by bacteria commonly found in water and soil. These bacteria are everywhere — in showerheads, household plumbing,...
Understanding Rare Lung Diseases: Why Awareness Saves Lives
🫁 Understanding Rare Lung Diseases: Why Awareness Saves Lives Breathing Shouldn’t Be a Struggle Most of us don’t think twice about breathing — until something makes it difficult. For people living with rare lung diseases, every breath can be a reminder of how...
MAC is NTM: Understanding the Connection Between These Two Terms
MAC is NTM: Understanding the Connection Between These Two Terms Many patients newly diagnosed with a mycobacterial lung infection are often confused by the terminology used. You may have heard your doctor mention “MAC” or “NTM” — sometimes interchangeably — and...
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support Every year on August 4th, we come together to recognize World NTM Awareness Day, a global movement dedicated to raising awareness about nontuberculous mycobacterial (NTM)...
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference Held May 14–15 in Berkeley, California and Online The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and...
Supporting Mental Health for the NTM Community: Mental Health Awareness Month
Supporting Mental Health for the NTM Community: Mental Health Awareness Month May is Mental Health Awareness Month, a time to shine a light on the importance of emotional well-being — especially for those living with chronic illnesses like NTM (nontuberculous...
220000
ESTIMATED CASES
OF NTM IN THE US
IN 2020
8.2 %
THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR
2.8m
ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR
